Floatz logo

Cromoglicic acid

Gastroesophageal Reflux

University of California, San FranciscoSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Gastroesophageal Reflux cohort.

Asset / SponsorPhaseRating
Lansoprazole
Children's Mercy Hospital Kansas City
Phase 4BB
PANTOPRAZOLE
Children's Mercy Hospital Kansas City
Phase 4BB
MIDAZOLAM
Children's Mercy Hospital Kansas City
Phase 4BB
Dexlansoprazole
National Cheng-Kung University Hospital
Phase 4BB
LIDOCAINE
Hospital Infantil Cândido Fontoura
Phase 3BB

View all 17 →

Same molecule, other indications

Cromoglicic acid is also rated in:

stroke disorderDormant
B
Indicative ·
57 / 100
View asset →
Alzheimer diseaseDormant
CCC
Indicative ·
54 / 100
View asset →
Alzheimer DiseaseDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →